Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $758.70 | 46 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $175.43 | 12 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $167.85 | 9 | $0 (2023) |
| ABBVIE INC. | $106.65 | 6 | $0 (2024) |
| Allergan, Inc. | $77.08 | 5 | $0 (2020) |
| Merck Sharp & Dohme LLC | $66.87 | 4 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $53.92 | 4 | $0 (2019) |
| Paratek Pharmaceuticals, Inc. | $34.96 | 2 | $0 (2024) |
| Mylan Specialty L.P. | $23.07 | 1 | $0 (2024) |
| PFIZER INC. | $20.74 | 1 | $0 (2021) |
| Gilead Sciences, Inc. | $17.13 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $78.27 | 4 | Paratek Pharmaceuticals, Inc. ($34.96) |
| 2023 | $100.18 | 5 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($85.60) |
| 2022 | $179.63 | 11 | Janssen Pharmaceuticals, Inc ($58.70) |
| 2021 | $137.71 | 8 | Janssen Pharmaceuticals, Inc ($46.18) |
| 2020 | $28.82 | 2 | Allergan, Inc. ($28.82) |
| 2019 | $148.72 | 10 | E.R. Squibb & Sons, L.L.C. ($53.92) |
| 2018 | $71.77 | 5 | Allergan Inc. ($29.13) |
| 2017 | $13.60 | 1 | Janssen Pharmaceuticals, Inc ($13.60) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: ANTIBIOTIC | ||||||
| 08/14/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/30/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE, AVYCAZ | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/23/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: ANTIBIOTIC | ||||||
| 11/08/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/04/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/06/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/30/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/24/2023 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/07/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $21.40 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/30/2022 | ABBVIE INC. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $13.40 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/10/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/14/2022 | ABBVIE INC. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/16/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $12.59 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/08/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.08 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/26/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA, RECARBRIO | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/10/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/06/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/05/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.13 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 02/15/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/01/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/23/2021 | AbbVie Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: ANTI-INFECTIVE | ||||||
| 05/20/2021 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $17.13 | General |
| Category: COVID-19 | ||||||
| 04/14/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/08/2021 | AbbVie Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 368 | 714 | $149,244 | $47,854 |
| 2022 | 8 | 461 | 822 | $165,808 | $55,728 |
| 2021 | 12 | 474 | 823 | $168,202 | $57,166 |
| 2020 | 12 | 637 | 1,127 | $225,525 | $78,376 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 147 | 447 | $84,929 | $27,270 | 32.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 106 | 108 | $20,854 | $6,120 | 29.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 30 | 66 | $17,318 | $6,113 | 35.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 57 | 58 | $17,980 | $5,875 | 32.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $5,508 | $1,571 | 28.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 23 | $2,655 | $903.67 | 34.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 160 | 395 | $65,175 | $21,933 | 33.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 99 | 221 | $52,156 | $17,590 | 33.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 116 | 119 | $19,754 | $6,542 | 33.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 24 | 25 | $11,475 | $3,874 | 33.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 24 | 24 | $7,440 | $2,469 | 33.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 15 | 15 | $3,660 | $1,228 | 33.6% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 11 | 11 | $3,388 | $1,140 | 33.7% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 12 | 12 | $2,760 | $951.04 | 34.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 147 | 397 | $65,505 | $22,432 | 34.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 68 | 144 | $33,984 | $11,607 | 34.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 36 | 36 | $16,524 | $5,579 | 33.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 69 | 69 | $11,454 | $3,829 | 33.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 43 | 43 | $10,492 | $3,510 | 33.5% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 18 | 18 | $7,596 | $2,475 | 32.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 20 | 20 | $6,200 | $2,143 | 34.6% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 15 | 15 | $4,620 | $1,589 | 34.4% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 15 | 20 | $3,320 | $1,132 | 34.1% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 18 | 18 | $2,988 | $972.28 | 32.5% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 12 | 12 | $2,760 | $961.08 | 34.8% |
About Dr. Laco Mace, M.D
Dr. Laco Mace, M.D is a Internal Medicine healthcare provider based in Bridgeport, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1437339694.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Laco Mace, M.D has received a total of $758.70 in payments from pharmaceutical and medical device companies, with $78.27 received in 2024. These payments were reported across 46 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($758.70).
As a Medicare-enrolled provider, Mace has provided services to 1,940 Medicare beneficiaries, totaling 3,486 services with total Medicare billing of $239,123. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine, Hospitalist
- Location Bridgeport, WV
- Active Since 11/05/2007
- Last Updated 04/05/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1437339694
Products in Payments
- XARELTO (Drug) $175.43
- LifeVest (Device) $167.85
- AVYCAZ (Drug) $93.56
- ELIQUIS (Drug) $74.66
- TEFLARO (Drug) $73.23
- NUZYRA (Drug) $34.96
- DIFICID (Drug) $33.77
- ZERBAXA (Drug) $33.10
- YUPELRI (Drug) $23.07
- Veklury (Drug) $17.13
- DALVANCE (Drug) $16.94
- Ozempic (Drug) $15.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bridgeport
Nicholas Dainiak, M.d, M.D
Internal Medicine — Payments: $139,125
Stuart Zarich, M.d, M.D
Internal Medicine — Payments: $94,101
Sanjeev Rao, Md, MD
Internal Medicine — Payments: $33,954
Dr. Joao Nascimento, Md, MD
Internal Medicine — Payments: $30,705
Dr. Charles Rouse, M.d, M.D
Internal Medicine — Payments: $25,586
Dr. Doron Amir, Md, MD
Internal Medicine — Payments: $21,318